BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Btissame El Hassouni, Dzjemma Sarkisjan, J. Chris Vos, Elisa Giovannetti, Godefridus J. Peters. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid ChemoresistanceCurrent Medicinal Chemistry 2019; 26(33): 6020 doi: 10.2174/0929867326666181203133332
Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Sara M. Hamouda. Long non‐coding RNA FAM83H‐AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer Cell Biochemistry and Function 2021; 39(3): 350 doi: 10.1002/cbf.3601
Roberta Peruzzo, Andrea Mattarei, Matteo Romio, Cristina Paradisi, Mario Zoratti, Ildikò Szabò, Luigi Leanza. Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma CellsFrontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00239
Herve Tiriac, Juan Carlos Bucobo, Demetrios Tzimas, Suman Grewel, Joseph F. Lacomb, Leahana M. Rowehl, Satish Nagula, Maoxin Wu, Joseph Kim, Aaron Sasson, Shivakumar Vignesh, Laura Martello, Maria Munoz-Sagastibelza, Jonathan Somma, David A. Tuveson, Ellen Li, Jonathan M. Buscaglia. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatmentGastrointestinal Endoscopy 2018; 87(6): 1474 doi: 10.1016/j.gie.2017.12.032
Zengyu Feng, Minmin Shi, Kexian Li, Yang Ma, Lingxi Jiang, Hao Chen, Chenghong Peng. Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinomaJournal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02527-1
Ning Pu, Yang Lv, Guochao Zhao, Wanling Lee, Abulimiti Nuerxiati, Dansong Wang, Xuefeng Xu, Tiantao Kuang, Wenchuan Wu, Wenhui Lou. Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimateFuture Oncology 2018; 14(2): 165 doi: 10.2217/fon-2017-0380
Md Asad Ullah, Bishajit Sarkar, Fayza Akter. Prediction of biomarker signatures and therapeutic agents from blood sample against Pancreatic Ductal Adenocarcinoma (PDAC): A network-based studyInformatics in Medicine Unlocked 2020; 19: 100346 doi: 10.1016/j.imu.2020.100346